Patents by Inventor Nang-Su Oh

Nang-Su Oh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Gastric carcinoma gene ZNF312b, a protein translated from the gene, and a diagnostic kit and a screening method for anticancer agents using the same
    Patent number: 8278285
    Abstract: The present invention relates to a diagnostic marker containing ZNF312b gene and the fragment thereof, a diagnostic method for stomach cancer and a screening method for stomach cancer inducers or inhibitors using the same. ZNF312b gene expression is specifically increased in stomach cancer. And the over-expression or the under-expression of the gene affects activation or inhibition of cell proliferation and tumor formation of a stomach cancer cell line and cell proliferation signal transduction system as well to induce stomach cancer at last. Therefore, ZNF312b marker gene can be effectively used for diagnosis of stomach cancer, construction of a stomach cancer animal model, prevention and treatment of stomach cancer and development of a stomach cancer specific anticancer agent.
    Type: Grant
    Filed: August 6, 2008
    Date of Patent: October 2, 2012
    Assignee: Korea Research Institute of Bioscience and Biotechnology
    Inventors: Nam-Soon Kim, In-Sung Song, Nang-Su Oh, So-Young Jeong, Ga-Hee Ha, Yeo-Jin Jeon, Jeong-Min Kim, Cheol-Hee Kim, Hyun-Taek Kim
  • GASTRIC CARCINOMA GENE ZNF312B, A PROTEIN TRANSLATED FROM THE GENE, AND A DIAGNOSTIC KIT AND A SCREENING METHOD FOR ANTICANCER AGENTS USING THE SAME
    Publication number: 20100162420
    Abstract: The present invention relates to a diagnostic marker containing ZNF312b gene and the fragment thereof, a diagnostic method for stomach cancer and a screening method for stomach cancer inducers or inhibitors using the same. ZNF312b gene expression is specifically increased in stomach cancer. And the over-expression or the under-expression of the gene affects activation or inhibition of cell proliferation and tumor formation of a stomach cancer cell line and cell proliferation signal transduction system as well to induce stomach cancer at last. Therefore, ZNF312b marker gene can be effectively used for diagnosis of stomach cancer, construction of a stomach cancer animal model, prevention and treatment of stomach cancer and development of a stomach cancer specific anticancer agent.
    Type: Application
    Filed: August 6, 2008
    Publication date: June 24, 2010
    Inventors: Nam-Soon Kim, In-Sung Song, Nang-Su Oh, So-Young Jeong, Ga-Hee Ha, Yeo-Jin Jeon, Jeong-Min Kim, Cheol-Hee Kim, Hyun-Taek Kim